Breast Cancer Drug Gets a Unanimous Thumbs Down – ScienceInsider
“Some members of the advisory committee pointed to a downside in today’s decision to strip the drug of its breast cancer label: This could undermine...
“Some members of the advisory committee pointed to a downside in today’s decision to strip the drug of its breast cancer label: This could undermine...